BACKGROUND: Post-traumatic stress disorder (PTSD) is associated with elevated risk for metabolic syndrome (MetS). However, the direction of this association is not yet established, as most prior studies employed cross-sectional designs. The primary goal of this study was to evaluate bidirectional associations between PTSD and MetS using a longitudinal design. METHOD: A total of 1355 male and female veterans of the conflicts in Iraq and Afghanistan underwent PTSD diagnostic assessments and their biometric profiles pertaining to MetS were extracted from the electronic medical record at two time points (spanning ~2.5 years, n = 971 at time 2). RESULTS: The prevalence of MetS among veterans with PTSD was just under 40% at both time points and was significantly greater than that for veterans without PTSD; the prevalence of MetS among those with PTSD was also elevated relative to age-matched population estimates. Cross-lagged panel models revealed that PTSD severity predicted subsequent increases in MetS severity (β = 0.08, p = 0.002), after controlling for initial MetS severity, but MetS did not predict later PTSD symptoms. Logistic regression results suggested that for every 10 PTSD symptoms endorsed at time 1, the odds of a subsequent MetS diagnosis increased by 56%. CONCLUSIONS: Results highlight the substantial cardiometabolic concerns of young veterans with PTSD and raise the possibility that PTSD may predispose individuals to accelerated aging, in part, manifested clinically as MetS. This demonstrates the need to identify those with PTSD at greatest risk for MetS and to develop interventions that improve both conditions.
BACKGROUND: Post-traumatic stress disorder (PTSD) is associated with elevated risk for metabolic syndrome (MetS). However, the direction of this association is not yet established, as most prior studies employed cross-sectional designs. The primary goal of this study was to evaluate bidirectional associations between PTSD and MetS using a longitudinal design. METHOD: A total of 1355 male and female veterans of the conflicts in Iraq and Afghanistan underwent PTSD diagnostic assessments and their biometric profiles pertaining to MetS were extracted from the electronic medical record at two time points (spanning ~2.5 years, n = 971 at time 2). RESULTS: The prevalence of MetS among veterans with PTSD was just under 40% at both time points and was significantly greater than that for veterans without PTSD; the prevalence of MetS among those with PTSD was also elevated relative to age-matched population estimates. Cross-lagged panel models revealed that PTSD severity predicted subsequent increases in MetS severity (β = 0.08, p = 0.002), after controlling for initial MetS severity, but MetS did not predict later PTSD symptoms. Logistic regression results suggested that for every 10 PTSD symptoms endorsed at time 1, the odds of a subsequent MetS diagnosis increased by 56%. CONCLUSIONS: Results highlight the substantial cardiometabolic concerns of young veterans with PTSD and raise the possibility that PTSD may predispose individuals to accelerated aging, in part, manifested clinically as MetS. This demonstrates the need to identify those with PTSD at greatest risk for MetS and to develop interventions that improve both conditions.
Authors: Raymond C Rosen; Brian P Marx; Nancy N Maserejian; Darren W Holowka; Margaret A Gates; Lynn A Sleeper; Jennifer J Vasterling; Han K Kang; Terence M Keane Journal: Int J Methods Psychiatr Res Date: 2011-11-16 Impact factor: 4.035
Authors: Michelle J Bovin; Brian P Marx; Frank W Weathers; Matthew W Gallagher; Paola Rodriguez; Paula P Schnurr; Terence M Keane Journal: Psychol Assess Date: 2015-12-14
Authors: Satish A Eraly; Caroline M Nievergelt; Adam X Maihofer; Donald A Barkauskas; Nilima Biswas; Agorastos Agorastos; Daniel T O'Connor; Dewleen G Baker Journal: JAMA Psychiatry Date: 2014-04 Impact factor: 21.596
Authors: Anna Gavrieli; Olivia M Farr; Cynthia R Davis; Judith A Crowell; Christos S Mantzoros Journal: Metabolism Date: 2015-09-26 Impact factor: 8.694
Authors: Darrel A Regier; William E Narrow; Diana E Clarke; Helena C Kraemer; S Janet Kuramoto; Emily A Kuhl; David J Kupfer Journal: Am J Psychiatry Date: 2013-01 Impact factor: 18.112
Authors: Ali Zandieh; Alireza Esteghamati; Afsaneh Morteza; Sina Noshad; Omid Khalilzadeh; Mohammad Mehdi Gouya; Manouchehr Nakhjavani Journal: Ann Hum Biol Date: 2012-09-05 Impact factor: 1.533
Authors: Aarti Gautam; Peter D'Arpa; Duncan E Donohue; Seid Muhie; Nabarun Chakraborty; Brian T Luke; Dmitry Grapov; Erica E Carroll; James L Meyerhoff; Rasha Hammamieh; Marti Jett Journal: PLoS One Date: 2015-01-28 Impact factor: 3.240
Authors: J A Sumner; L E Duncan; E J Wolf; A B Amstadter; D G Baker; J C Beckham; B Gelaye; S Hemmings; N A Kimbrel; M W Logue; V Michopoulos; K S Mitchell; C Nievergelt; A Rothbaum; S Seedat; G Shinozaki; E Vermetten Journal: Psychol Med Date: 2017-04-04 Impact factor: 7.723
Authors: Erika J Wolf; Filomene G Morrison; Danielle R Sullivan; Mark W Logue; Rachel E Guetta; Annjanette Stone; Steven A Schichman; Regina E McGlinchey; William P Milberg; Mark W Miller Journal: Brain Behav Immun Date: 2019-03-11 Impact factor: 7.217
Authors: K C Koenen; J A Sumner; P Gilsanz; M M Glymour; A Ratanatharathorn; E B Rimm; A L Roberts; A Winning; L D Kubzansky Journal: Psychol Med Date: 2016-10-04 Impact factor: 7.723
Authors: Samantha L Connolly; Tawni B Stoop; Mark W Logue; Esther Hana Orr; Immaculata De Vivo; Mark W Miller; Erika J Wolf Journal: J Trauma Stress Date: 2018-10-19
Authors: Erika J Wolf; Danielle R Miller; Mark W Logue; Jennifer Sumner; Tawni B Stoop; Elizabeth C Leritz; Jasmeet P Hayes; Annjanette Stone; Steven A Schichman; Regina E McGlinchey; William P Milberg; Mark W Miller Journal: Brain Behav Immun Date: 2017-06-01 Impact factor: 7.217